Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
Quick Find - Click to open on a page
HomeAbout MerckProductsNewsroomInvestor RelationsCareersResearchLicensingThe Merck Manuals
Contact Contact Investor Relations
E-mail alerts Sign up for E-mail Alerts
PODCAST Investor Relations Podcast
  RSS RSS

Investor Relations

Welcome to the Merck Investor Center
This site is designed to provide analysts and investors (institutional or retail) with quick and easy access to reliable, accurate and current information about Merck. Here you will find information on; historical company earnings, webcasts, presentations, transcripts, SEC filings, stock information and partnership information. For additional information, please visit About Merck.

News
06/29/2009 Nation's Top 37 Minority Students Awarded Prestigious UNCF/MERCK Science Scholarships & Fellowships
06/22/2009 Merck Prices $4.25 Billion Debt Offering
06/22/2009 Merck and Schering-Plough Receive Request for Additional Information from FTC Regarding Proposed Merger
06/22/2009 Merck & Co., Inc. and Drugs for Neglected Diseases initiative Collaborate to Find Treatments for World's Most Neglected Tropical Diseases

*Software to view files presented in PDF or SWF format is available at no charge through the Adobe Web site. Get Adobe Reader Get Adobe Flash Player

Printer Friendly Page
 

Stock Quote

Latest prices for Merck stock Stock quote (opens new window)
A New Merck: Merck and Schering-Plough to Merge

2008 Annual Report

Read the 2008 Annual Report: Building the New Merck

VIOXX Withdrawal

Information on the voluntary withdrawal of
VIOXX® (rofecoxib)

Corporate Responsibility

Corporate Responsibility

Read report

Corporate Governance

Focusing on the Company's strategic and operational excellence and on the best interests of our shareholders

Merck Pipeline

A summary of the company's research pipeline
 
Contact Merck Site Map Accessibility Statement Privacy Policy Terms of Use Copyright 1995-2008 Merck & Co., Inc.